Average Co-Inventor Count = 9.00
ph-index = 16
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Gilead Sciences, Inc. (58 from 924 patents)
2. Gilead Pharmasset LLC (6 from 81 patents)
3. Lilac Therapeutics, Inc. (2 from 4 patents)
66 patents:
1. 12448400 - KRAS G12D modulating compounds
2. 12421235 - Bridged tricyclic carbamoylpyridone compounds and uses thereof
3. 12377100 - Toll like receptor modulator compounds
4. 12240862 - Inhibitors of peptidylarginine deiminases
5. 12227520 - Bridged tricyclic carbamoylpyridone compounds and their pharmaceutical use
6. 12168002 - Heterocyclic carboxylate compounds as glycolate oxidase inhibitors
7. 12161625 - Substituted pyrrolizine compounds and uses thereof
8. 11976083 - Inhibitors of peptidylarginine deiminases
9. 11883397 - Substituted pyrido[1,2-a]pyrrolo[1,2-d]pyrazines for treating viral infections
10. 11878965 - Inhibitors of peptidylarginine deiminases
11. 11806335 - Heterocyclic carboxylate compounds as glycolate oxidase inhibitors
12. 11548902 - Bridged tricyclic carbamoylpyridone compounds and their pharmaceutical use
13. 11548901 - Substituted 1,4-methanopyrido[1',2′:4,5]pyrazino[1,2-a]pyrimidines for treating viral infections
14. 11420974 - Substituted pyrrolizine compounds and uses thereof
15. 11253524 - Metabolites of bictegravir